<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36951877</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1473-5628</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>Nuclear medicine communications</Title><ISOAbbreviation>Nucl Med Commun</ISOAbbreviation></Journal><ArticleTitle>Investigating the potential added value of [ 18 F]FDG-PET/CT in long COVID patients with persistent symptoms: a proof of concept study.</ArticleTitle><Pagination><StartPage>495</StartPage><EndPage>501</EndPage><MedlinePgn>495-501</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/MNM.0000000000001689</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Since the end of 2019, the coronavirus disease 2019 (COVID-19) virus has infected millions of people, of whom a significant group suffers from sequelae from COVID-19, termed long COVID. As more and more patients emerge with long COVID who have symptoms of fatigue, myalgia and joint pain, we must examine potential biomarkers to find quantifiable parameters to define the underlying mechanisms and enable response monitoring. The aim of this study is to investigate the potential added value of [ 18 F]FDG-PET/computed tomography (CT) for this group of long COVID patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">For this proof of concept study, we evaluated [ 18 F]FDG-PET/CT scans of long COVID patients and controls. Two analyses were performed: semi-quantitative analysis using target-to-background ratios (TBRs) in 24 targets and total vascular score (TVS) assessed by two independent nuclear medicine physicians. Mann-Whitney U -test was performed to find significant differences between the two groups.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirteen patients were included in the long COVID group and 25 patients were included in the control group. No significant differences ( P &#x2005;&lt;&#x2005;0.05) were found between the long COVID group and the control group in the TBR or TVS assessment.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">As we found no quantitative difference in the TBR or TVS between long COVID patients and controls, we are unable to prove that [ 18 F]FDG is of added value for long COVID patients with symptoms of myalgia or joint pain. Prospective cohort studies are necessary to understand the underlying mechanisms of long COVID.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Linda L</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, Alrijne Hospital, Leiderdorp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Technical Medicine, Faculty of 3mE, Delft University of Technology, Delft.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology, Section of Nuclear Medicine, Leiden University Medical Center (LUMC), Leiden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiation Therapy, Erasmus University Medical Center, Rotterdam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van de Burgt</LastName><ForeName>Alina</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, Alrijne Hospital, Leiderdorp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology, Section of Nuclear Medicine, Leiden University Medical Center (LUMC), Leiden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smit</LastName><ForeName>Frits</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, Alrijne Hospital, Leiderdorp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology, Section of Nuclear Medicine, Leiden University Medical Center (LUMC), Leiden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Audhoe</LastName><ForeName>Rowena S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, Alrijne Hospital, Leiderdorp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Boer</LastName><ForeName>Sandra M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, Alrijne Hospital, Leiderdorp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Velden</LastName><ForeName>Floris H P</ForeName><Initials>FHP</Initials><AffiliationInfo><Affiliation>Department of Radiology, Section of Nuclear Medicine, Leiden University Medical Center (LUMC), Leiden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Geus-Oei</LastName><ForeName>Lioe-Fee</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Department of Radiology, Section of Nuclear Medicine, Leiden University Medical Center (LUMC), Leiden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Photonic Imaging Group, Twente University, Enschede.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiation Science &amp; Technology, Delft University of Technology, Delft, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nucl Med Commun</MedlineTA><NlmUniqueID>8201017</NlmUniqueID><ISSNLinking>0143-3636</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0Z5B2CJX4D</RegistryNumber><NameOfSubstance UI="D019788">Fluorodeoxyglucose F18</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019275">Radiopharmaceuticals</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019788" MajorTopicYN="Y">Fluorodeoxyglucose F18</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072078" MajorTopicYN="N">Positron Emission Tomography Computed Tomography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000075082" MajorTopicYN="N">Proof of Concept Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063806" MajorTopicYN="N">Myalgia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019275" MajorTopicYN="N">Radiopharmaceuticals</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>There are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>12</Day><Hour>7</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>23</Day><Hour>11</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36951877</ArticleId><ArticleId IdType="pmc">PMC10171287</ArticleId><ArticleId IdType="doi">10.1097/MNM.0000000000001689</ArticleId><ArticleId IdType="pii">00006231-202306000-00011</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shi Y, Wang G, Cai X, Deng J, Zheng L, Zhu H, et al. . An overview of COVID-19. J Zhejiang Univ Sci B 2020; 21:343&#x2013;360.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7205601</ArticleId><ArticleId IdType="pubmed">32425000</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. . Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA &#x2013; J Am Med Assoc 2020; 323:1061&#x2013;1069.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue H, Bai X, Wang J, Yu Q, Liu W, Pu J, et al. . Clinical characteristics of coronavirus disease 2019 in Gansu province, China. Ann Cardiothorac Surg 2020; 9:1404&#x2013;1412.</Citation><ArticleIdList><ArticleId IdType="pubmed">32692208</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal A, Iqbal K, Arshad Ali S, Azim D, Farid E, Baig MD, et al. . The COVID-19 sequelae: a cross-sectional evaluation of post-recovery symptoms and the need for rehabilitation of COVID-19 survivors. Cureus 2021; 2:e13080.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7932827</ArticleId><ArticleId IdType="pubmed">33680620</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA &#x2013; J Am Med Assoc 2020; 323:1239&#x2013;1242.</Citation><ArticleIdList><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A V, Jayadevan R, Sashidharan S. Long COVID: an overview. Diabetes Metab Syndr 2021; 15:869&#x2013;875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med [Internet] 2021; 18:1&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine 2021; 38:101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw B, Daskareh M, Gholamrezanezhad A. The lingering manifestations of COVID-19 during and after convalescence: update on long-term pulmonary consequences of coronavirus disease 2019 (COVID-19). Radiol Medica [Internet] 2021; 126:40&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7529085</ArticleId><ArticleId IdType="pubmed">33006087</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. N Engl J Med 2020; 324:603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqi HK, Libby P, Ridker PM. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19. The COVID-19 resource centre is hosted on Elsevier Connect, the company&#x2019; s public news and information. Trends 2020; 31:1&#x2013;5.</Citation></Reference><Reference><Citation>Zacharias H, Dubey S, Koduri G, Cruz DD. Rheumatological complications of Covid 19. Autoimmun Rev 2021; 20:102883.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8256657</ArticleId><ArticleId IdType="pubmed">34237419</ArticleId></ArticleIdList></Reference><Reference><Citation>Derksen VFAM, Kissel T, Lamers-Karnebeek FBG, Van Der Bijl AE, Venhuizen AC, Huizinga TWJ, et al. . Onset of rheumatoid arthritis after COVID-19: coincidence or connected? Ann Rheum Dis 2021; 80:1096&#x2013;1098.</Citation><ArticleIdList><ArticleId IdType="pubmed">33648960</ArticleId></ArticleIdList></Reference><Reference><Citation>Viner R, Whittaker E. Kawasaki-like disease: emerging complication during the COVID-19 pandemic. Lancet 2020; 395:1741&#x2013;1743.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7220168</ArticleId><ArticleId IdType="pubmed">32410759</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamar F, Buscombe J, Chiti A, Christian PE, Delbeke D, Donohoe KJ, et al. . EANM/SNMMI guideline for 18F-FDG use in inflammation and infection. J Nucl Med 2013; 54:647&#x2013;658.</Citation><ArticleIdList><ArticleId IdType="pubmed">23359660</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M, Ciccarelli M, Cecconi M, Aghemo A, Morelli P, Gelardi F, et al. . Vasculitis changes in COVID-19 survivors with persistent symptoms: an [(18)F]FDG-PET/CT study. Eur J Nucl Med Mol Imaging 2021; 48:1460&#x2013;1466.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7595761</ArticleId><ArticleId IdType="pubmed">33123760</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M, Morbelli S, Ciccarelli M, Cecconi M, Aghemo A, Morelli P, et al. . Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study. Eur J Nucl Med Mol Imaging 2021; 48:3187&#x2013;3197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7937050</ArticleId><ArticleId IdType="pubmed">33677642</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez-Alfonso B, Ruiz Sol&#xed;s S, Silva-Hern&#xe1;ndez L, Pintos Pascual I, Aguado Ib&#xe1;&#xf1;ez S, Salas Ant&#xf3;n C. (18)F-FDG-PET/CT in SARS-CoV-2 infection and its sequelae. Rev Esp Med Nucl Imagen Mol (Engl Ed) 2021; 40:299&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8316133</ArticleId><ArticleId IdType="pubmed">34340958</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan T, Einstein SA, Kappadath SC, Grogg KS, Lois Gomez C, Alessio AM, et al. . Performance evaluation of the 5-Ring GE Discovery MI PET/CT system using the national electrical manufacturers association NU 2-2012 Standard. Med Phys 2019; 46:3025&#x2013;3033.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7251507</ArticleId><ArticleId IdType="pubmed">31069816</ArticleId></ArticleIdList></Reference><Reference><Citation>Keyes J, Jr. SUV: standard uptake or silly useless value?
J Nucl Med [Internet] 1995; 36:1836&#x2013;1839. http://www.osti.gov/scitech/biblio/478317.</Citation><ArticleIdList><ArticleId IdType="pubmed">7562051</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinahan PE, Fletcher JW. Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy. Semin Ultrasound CT MRI 2010; 31:496&#x2013;505.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3026294</ArticleId><ArticleId IdType="pubmed">21147377</ArticleId></ArticleIdList></Reference><Reference><Citation>Slart RHJA, Slart RHJA, Glaudemans AWJM, Chareonthaitawee P, Treglia G, Besson FL, et al. . FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. Eur J Nucl Med Mol Imaging 2018; 45:1250&#x2013;1269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5954002</ArticleId><ArticleId IdType="pubmed">29637252</ArticleId></ArticleIdList></Reference><Reference><Citation>Boellaard R, Krak NC, Hoekstra OS, Lammertsma A, Jaskowiak CJ, Bianco J, et al. . Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study.
J Nucl Med [Internet] 2002; 45:670&#x2013;678. http://www.ncbi.nlm.nih.gov/pubmed/15750154%5Cnhttp://www.ncbi.nlm.nih.gov/pubmed/15347719.</Citation><ArticleIdList><ArticleId IdType="pubmed">15347719</ArticleId></ArticleIdList></Reference><Reference><Citation>Sedgwick P. Multiple significance tests: the Bonferroni correction. BMJ 2012; 344:e5091&#x2013;ee509.</Citation></Reference><Reference><Citation>Curtin F, Schulz P. Multiple correlations and Bonferroni&#x2019;s correction. Biol Psychiatry 1998; 44:775&#x2013;777.</Citation><ArticleIdList><ArticleId IdType="pubmed">9798082</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehak Z, Sprlakova-Pukova A, Kazda T, Fojtik Z, Vargova L, Nemec P. (18)F-FDG PET/CT in polymyalgia rheumatica-a pictorial review. Br J Radiol 2017; 90:20170198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5603955</ArticleId><ArticleId IdType="pubmed">28508663</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehak Z, Vasina J, Nemec P, Fojtik Z, Koukalova R, Bortlicek Z, et al. . Various forms of (18)F-FDG PET and PET/CT findings in patients with polymyalgia rheumatica. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2015; 159:629&#x2013;636.</Citation><ArticleIdList><ArticleId IdType="pubmed">26006092</ArticleId></ArticleIdList></Reference><Reference><Citation>Maiese A, Manetti AC, La Russa R, Di Paolo M, Turillazzi E, Frati P, et al. . Autopsy findings in COVID-19-related deaths: a literature review. Forensic Sci Med Pathol 2021; 17:279&#x2013;296.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7538370</ArticleId><ArticleId IdType="pubmed">33026628</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby P, L&#xfc;scher T. COVID-19 is, in the end, an endothelial disease. Eur Heart J 2020; 41:3038&#x2013;3044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7470753</ArticleId><ArticleId IdType="pubmed">32882706</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai Y, Xu J, Chen L, Fu C, Kang Y, Zhang W, et al. . Inflammatory response in lungs and extrapulmonary sites detected by [(18)F] fluorodeoxyglucose PET/CT in convalescing COVID-19 patients tested negative for coronavirus. Eur J Nucl Med Mol Imaging 2021; 48:2531&#x2013;2542.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7794623</ArticleId><ArticleId IdType="pubmed">33420914</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaalep A, Burggraaff CN, Pieplenbosch S, Verwer EE, Sera T, Zijlstra J, et al. . Quantitative implications of the updated EARL 2019 PET&#x2013;CT performance standards. EJNMMI Phys 2019; 6:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6933045</ArticleId><ArticleId IdType="pubmed">31879795</ArticleId></ArticleIdList></Reference><Reference><Citation>Lensen KJDF, Van Sijl AM, Voskuyl AE, Van Der Laken CJ, Heymans MW, Comans EFI, et al. . Variability in quantitative analysis of atherosclerotic plaque inflammation using 18F-FDG PET/CT. PLoS One 2017; 12:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5553940</ArticleId><ArticleId IdType="pubmed">28800625</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>